Astellas Pharma, Inc. (ALPMF)
15.70
+2.05
(+15.02%)
USD |
OTCM |
May 15, 16:00
Astellas Pharma EPS Diluted (Quarterly) : 0.1543 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.4688 |
| Takeda Pharmaceutical Co., Ltd. | -0.0496 |
| Daiichi Sankyo Co., Ltd. | 0.1472 |
| Eisai Co., Ltd. | -0.0184 |
| Chugai Pharmaceutical Co., Ltd. | 0.2235 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 278.00M |
| Revenue (Quarterly) | 3.429B |
| Total Expenses (Quarterly) | 3.151B |
| Enterprise Value | 29.91B |
| Gross Profit Margin (Quarterly) | 75.94% |
| Profit Margin (Quarterly) | 8.11% |
| Earnings Yield | 6.87% |
| Operating Earnings Yield | 9.90% |